Illumina, Inc. (LON:0J8Z)
London · Delayed Price · Currency is GBP · Price in USD 98.17
+0.68 (0.70%)
At close: Sep 9, 2025
Illumina Market Cap
Illumina has a market cap or net worth of 11.16 billion as of September 10, 2025. Its market cap has decreased by -29.10% in one year.
Market Cap
11.16B
Enterprise Value
12.22B
Revenue
3.12B
Ranking
n/a
PE Ratio
12.17
Stock Price
98.17
Market Cap Chart
Since July 28, 2000, Illumina's market cap has increased from 174.80M to 11.16B, an increase of 6,281.97%. That is a compound annual growth rate of 17.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2025 | 11.16B | -34.10% |
| Dec 31, 2024 | 16.93B | -2.48% |
| Dec 29, 2023 | 17.36B | -34.24% |
| Dec 30, 2022 | 26.40B | -39.89% |
| Dec 31, 2021 | 43.92B | 10.99% |
| Dec 31, 2020 | 39.57B | 7.46% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 187.48B |
| GSK plc | 59.44B |
| Haleon | 32.74B |
| Smith & Nephew | 12.30B |
| ConvaTec Group | 4.86B |
| Hikma Pharmaceuticals | 3.81B |
| HUTCHMED (China) | 2.01B |
| Genus | 1.76B |